OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
58
Results
Show all
Save search
Copy query
Show results for
Unknown
(58)
Publication Date
Release Date
2025
(10)
2024
(8)
2020
(7)
2019
(6)
2021
(5)
2017
(5)
2022
(4)
2018
(4)
2023
(3)
2016
(2)
2015
(1)
2014
(1)
2013
(1)
2012
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.
Not available
S-EPMC5691891
|
biostudies-literature
Cite
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy.
Not available
S-EPMC6562626
|
biostudies-literature
Cite
Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer.
Not available
S-EPMC6140817
|
biostudies-literature
Cite
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.
Not available
S-EPMC7191187
|
biostudies-literature
Cite
Neoadjuvant Trastuzumab, Pertuzumab, and Docetaxel vs Trastuzumab Emtansine in Patients With ERBB2-Positive Breast Cancer: A Phase 2 Randomized Clinical Trial.
Not available
S-EPMC8227457
|
biostudies-literature
Cite
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?
Not available
S-EPMC6695578
|
biostudies-literature
Cite
Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort study.
Not available
S-EPMC12572808
|
biostudies-literature
Cite
Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes.
Not available
S-EPMC5342715
|
biostudies-literature
Cite
Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study.
Not available
S-EPMC11895130
|
biostudies-literature
Cite
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations.
Not available
S-EPMC6107481
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
